For example, gene expression signatures in colon adenocarcinoma (COAD) and glioblastoma (GBM) stratified tumors with aberrant KRAS and NF1 function, respectively (Guinney et al., 2014; Way et al., 2017). This evidence concerns the gene KRAS and glioblastoma.